Skip to main content

Table 1 Inappropriate medication criteria excluded from the analysis

From: Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities

Excluded from the criteria independent of disease or condition:
Because the drugs were unavailable in Japan
Propoxyphene Hyoscyamine
Trimethobenzamide Tripelennamine
Carisoprodol Dexchlorpheniramine
Medaxalone Cyclandelate
Cyclobenzaprine Meperidine
Chlordiazepoxide-amitriptyline Ketorolac
Perphenazine-amitriptyline Daily fluoxetine
Doxepine Orphenadrine
Meprobamate Guanethidine
Oxazepam Guanadrel
Temazepam Nitrofurantoin
Clidinium-chlordiazepoxide Mesoridazine
Halazepam Mineral oil
Chlorazepate Amphetamines (excluding methylphenidate hydrochloride and anorexics)
Because long-term use could not be tracked
Long-term use of full-dosage, longer-half life, non-COX-selective NSAIDs
Long-term use of stimulant laxatives
Excluded from the criteria dependent on disease or condition:
Because the drug was unavailable in Japan
Seizure disorder (Bupropion was unavailable.)
Because the patients with these disease or conditions could not be identified
Gastric or duodenal ulcers SIADH/hyponatremia
Bladder outflow obstruction